MBL International, Des Plaines, USA
Marc Delcommenne is currently an Director of Research and Development at MBL International / MBL Bion. He is also an professor works in Rush University Medical Center, Chicago. He has published many articles in reputed journals. His research interest includes Biology, Immunology & microbiology.
Abstract : A Tetramer HLA-A*02:01 Platform amenable to exchange peptides can be used to measure and predict the biological activity of a cancer vaccine.